Celiac Disease in Adult Patients : Specific Autoantibodies in the Diagnosis, Monitoring, and Screening

Abstract EN

The increasing prevalence of celiac disease (CD), especially in adults, its atypical clinical presentation, and the strict, lifelong adherence to gluten-free diet (GFD) as the only option for healthy state create an imperative need for noninvasive methods that can effectively diagnose CD and monitor GFD.

Aim.

Evaluation of anti-endomysium (EmA) and anti-tissue transglutaminase IgA (tTG-A) antibodies in CD diagnosis, GFD monitoring, and first degree relatives screening in CD adult patients.

Methods.

70 newly diagnosed Greek adult patients, 70 controls, and 47 first degree relatives were tested for the presence of EmA and tTG-A.

The CD patients were monitored during a 3-year period.

Results.

EmA predictive ability for CD diagnosis was slightly better compared to tTG-A (P=0.043).

EmA could assess compliance with GFD already from the beginning of the diet, while both EmA and tTG-A had an equal ability to discriminate between strictly and partially compliant patients after the first semester and so on.

Screening of first degree relatives resulted in the identification of 2 undiagnosed CD cases.

Conclusions.

Both EmA and tTG-A are suitable markers in the CD diagnosis, in the screening of CD among first degree relatives, having also an equal performance in the long term monitoring.